Panacea Index Logo

Command Palette

Search for a command to run...

Effects of a lower limb walking exoskeleton on quality of life and activities of daily living in patients with complete spinal cord injury: A randomized controlled trial.

Technology and health care : official journal of the European Society for Engineering and Medicine
January 1, 2024
Xiaomin Hu et al. (15 authors)
Randomized Controlled TrialMulticenter StudyJournal ArticleHuman StudyClinical
Study Details

Study Goal

The researchers aimed to explore the effect of a lower limb walking exoskeleton on quality of life and functional independence in patients with motor complete spinal cord injury (SCI).

Results Summary

The study found a non-significant trend toward improved quality of life in the exoskeleton-assisted walking group, while functional independence scores improved in both groups, with only the conventional group showing significant improvement.

Population

Patients with motor complete spinal cord injury (SCI) (n=16).

Effective Dosage

40-50 minutes, 5 times/week using an AIDER powered robotic exoskeleton.

Duration

8 weeks

Interactions

None mentioned

Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
exoskeleton-assisted walking training using an AIDER powered robotic exoskeleton
increase
psychological health domain of WHOQOL-BREF
patients with motor complete SCI
no significant difference
an increasing tendency of scores
#1
exoskeleton-assisted walking training using an AIDER powered robotic exoskeleton
increase
physical health domain of WHOQOL-BREF
patients with motor complete SCI
no significant difference
an increasing tendency of scores
#2
exoskeleton-assisted walking training using an AIDER powered robotic exoskeleton
increase
social relationships domain of WHOQOL-BREF
patients with motor complete SCI
no significant difference
an increasing tendency of scores
#3
conventional rehabilitation training
increase
SCIM-III scores
patients with motor complete SCI
significant difference
SCIM-III scores increased
#4
exoskeleton-assisted walking training using an AIDER powered robotic exoskeleton
increase
SCIM-III scores
patients with motor complete SCI
-
SCIM-III scores increased
#5
Abstract

BACKGROUND: In recent years, lower limb walking exoskeletons have been widely used in the study of spinal cord injury (SCI). OBJECTIVE: To explore the effect of a lower limb walking exoskeleton on quality of life and functional independence in patients with motor complete SCI. METHODS: This was a multi-center, single blind, randomized controlled trial. A total of 16 SCI patients were randomly assigned to either the exoskeleton-assisted walking (EAW) group (n= 8) or the conventional group (n= 8). Both groups received conventional rehabilitation training, including aerobic exercise and strength training. The EAW group additionally conducted the exoskeleton-assisted walking training using an AIDER powered robotic exoskeleton for 40-50 minutes, 5 times/week for 8 weeks. World Health Organization quality of life-BREF (WHOQOL-BREF) and the Spinal Cord Independence Measure III (SCIM-III) were used for assessment before and after training. RESULTS: There was an increasing tendency of scores in the psychological health, physical health, and social relationships domain of WHOQOL-BREF in the EAW group after the intervention compared with the pre-intervention period, but there was no significant difference (P> 0.05). SCIM-III scores increased in both groups compared to pre-training, with only the conventional group showing a significant difference after 8 weeks of training (P< 0.05). CONCLUSION: A lower limb walking exoskeleton may have potential benefits for quality of life and activities of daily living in patients with motor complete SCI.

Medical Subject Headings (MeSH)
HumansActivities of Daily LivingExoskeleton DeviceQuality of LifeSingle-Blind MethodSpinal Cord InjuriesWalkingLower Extremity
Study Links
Quality Scores
SafetyNot Assessed
Efficacy65/10
Quality75/10
Citation Metrics
Total Citations5
Citations/Year5.0
Relative Citation Ratio2.68
Research Impact Scores
APT Score0.75
Weight Score2.76
Normalized Score0.61
Related Supplements